Short answer
Factor XIII activity testing measures whether factor XIII can help stabilize a new clot after the usual clotting cascade has formed it. It is a specialized bleeding-workup test because routine screening tests such as PT, aPTT, thrombin time, platelet count, and bleeding time can be normal in isolated factor XIII deficiency.
What the result can clarify
| Clue | Why factor XIII may enter the workup | What to ask next |
|---|---|---|
| Bleeding with normal PT/aPTT | Factor XIII acts late, after fibrin has already formed. | Was a quantitative activity assay ordered? |
| Delayed bleeding or wound problems | Weak clot stabilization can show up after injury, surgery, or delivery. | Is this inherited, acquired, or medication-related? |
| Pregnancy loss or umbilical bleeding | Inherited deficiency can show up early in life or as recurrent pregnancy loss. | Is a genetic or family workup needed? |
| Very low activity | Severe inherited deficiency can be high risk. | Is hematology managing replacement or prevention? |
Inherited versus acquired deficiency
Inherited factor XIII deficiency is very rare and classically causes umbilical stump bleeding, delayed bleeding after trauma or surgery, abnormal wound healing, and heavy menstrual bleeding or miscarriage risk. Acquired low factor XIII activity can appear later in life and may be seen with autoimmune disease, malignancy, inflammatory bowel disease, sepsis, surgery, liver disease, or some medications.
Why normal screening tests do not rule it out
Factor XIII works at the final stabilization step, so the common clotting screens may not flag the problem. ARUP and Mayo both describe quantitative factor XIII activity as the key test when deficiency is suspected, while older clot-solubility approaches may miss mild or moderate deficiency.
Questions to ask
- Was the result a quantitative activity percentage or a qualitative screening test?
- Could liver disease, inflammation, cancer, sepsis, immune autoantibodies, or treatment history explain an acquired low result?
- Do family history, umbilical-cord bleeding, recurrent pregnancy loss, or delayed surgical bleeding suggest inherited deficiency?
- Should genetic testing, antigen testing, or inhibitor evaluation be considered?
What follow-up may include
Common follow-up may include a repeat activity assay, factor XIII antigen testing, inhibitor evaluation, genetic testing when inherited deficiency is suspected, or hematology-directed prophylaxis planning. If the result is low in an acquired pattern, clinicians usually also look for the underlying illness or trigger rather than treating the number in isolation.
FAQ
What does factor XIII activity testing measure?
It measures whether factor XIII is active enough to stabilize a clot after the earlier clotting steps have already happened.
Can factor XIII deficiency happen with normal PT and aPTT?
Yes. Normal screening tests do not rule out factor XIII deficiency because the factor acts after the standard clotting assays have already ended.
What symptoms make factor XIII deficiency more likely?
Delayed bleeding after surgery or trauma, poor wound healing, umbilical stump bleeding, heavy menstrual bleeding, and recurrent pregnancy loss are classic clues.
Is factor XIII deficiency inherited or acquired?
Both. Inherited deficiency is rare and usually due to F13A1 or F13B variants; acquired low activity can occur later from autoimmune, inflammatory, liver, cancer, or treatment-related causes.
What follow-up tests are common?
Clinicians may order factor XIII antigen testing, genetic testing, inhibitor evaluation, liver testing, or a broader bleeding workup depending on the story.
Is this a general screening test?
No. It is usually ordered when bleeding, wound healing, pregnancy loss, or a specific rare-factor question makes factor XIII a good fit.
Related guides: PT/INR blood test, aPTT blood test, coagulation factor assays, and fibrinogen blood test.